Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsBrueggemann, Angela B
Peto, Timothy E A
Crook, Derrick W
Butler, Jay C
Kristinsson, Karl G
Spratt, Brian G
MetadataShow full item record
CitationJ. Infect. Dis. 2004, 190(7):1203-11
AbstractA meta-analysis study design was used to analyze 7 data sets of invasive and carriage pneumococcal isolates recovered from children, to determine whether invasive disease potential differs for each serotype and, if so, whether it has changed over time or differs geographically. Serotype- and serogroup-specific odds ratios (ORs) were calculated for each study and as a pooled estimate, with use of serotype 14 as the reference group. ORs varied widely: the serotypes with the highest ORs (1, 5, and 7) were 60-fold more invasive than those with the lowest ORs (3, 6A, and 15). There was a significant inverse correlation between invasive disease and carriage prevalence for the serotypes that we considered, which implies that the most invasive serotypes and serogroups were the least commonly carried and that the most frequently carried were the least likely to cause invasive disease. There was no evidence of any temporal change or major geographical differences in serotype- or serogroup-specific invasive disease potential.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.
- Authors: Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG
- Issue date: 2003 May 1
- Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.
- Authors: Gonzalez BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO Jr, U.S. Pediatric Multicenter Pneumococcal Surveillance Group.
- Issue date: 2006 Apr
- Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
- Authors: Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R
- Issue date: 2009 Apr
- Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines.
- Authors: Laval CB, de Andrade AL, Pimenta FC, de Andrade JG, de Oliveira RM, Silva SA, de Lima EC, Fabio JL, Casagrande ST, Brandileone MC
- Issue date: 2006 Jan